IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Propel Bio Management, LLC

Q3 2025 Holdings

Filed 2025-11-12 | 16 holdings | $99.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Plains GP Holdings LP-Cl(PAGPEUR)LTD PARTNR INT A72651A207$23.2M1,272,36023.2%
Achieve Life Sciences Inc(ACHV)COM004468500$11.9M3,786,42511.9%
Akero Therapeutics Inc(AKRO)COM00973Y108$10.9M228,88410.9%
Milestone Pharmaceuticals(MIST)COM59935V107$10.2M5,124,89010.3%
Applied Therapeutics Inc(APLT)COM03828A101$6.8M11,285,4206.8%
Phathom Pharmaceuticals I(PHAT)COM71722W107$6.5M552,9276.5%
Abeona Therapeutics Inc(ABEO)COM NEW00289Y206$5.1M974,0225.1%
Delcath Systems Inc(DCTH)COM NEW24661P807$4.7M438,5094.7%
Celldex Therapeutics Inc(CLDX)COM NEW15117B202$4.0M155,0004.0%
Tscan Therapeutics Inc(TCRX)COM89854M101$3.5M1,932,3043.5%
Compass Pathways PLC(CMPS)SPONSORED ADS20451W101$2.9M510,0002.9%
Nektar Therapeutics(NKTR)COM NEW640268306$2.8M49,0002.8%
Jasper Therapeutics Inc(JSPR)COM NEW471871202$2.4M1,028,8062.5%
Zevra Therapeutics Inc(ZVRA)COM NEW488445206$2.2M231,8742.2%
Viridian Therapeutics Inc(VRDN)COM92790C104$1.9M90,0001.9%
Athira Pharma Inc(LONA)COM04746L203$618.0K149,2790.6%